GlassScriptPhysician profile
Neal Morris Jackson
NPI 1245522234
$8,487.70
in general payments reported to CMS, 2019-2025
12 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $308 · 2022: $269 · 2024: $5,990 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,678 · Food and Beverage: $2,420 · Education: $9.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,677.91 |
| Food and Beverage | $2,419.73 |
| Education | $9.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $5,530.37 | 2024-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Grace Medical, INC. | $1,127.67 | 2019-2025 | |
| Cochlear Americas | $842.47 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Advanced Bionics, LLC | $224.69 | 2019-2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Medtronic, INC. | $159.97 | 2024-2025 | Propel |
| Stryker Corporation | $141.79 | 2022 | |
| Olympus America INC. | $127.35 | 2022 | |
| Haag-Streit USA, INC. | $112.90 | 2020 | |
| Genzyme Corporation | $102.29 | 2024 | |
| Novartis Pharmaceuticals Corporation | $51.69 | 2024 | |
| Integra Lifesciences Corporation | $49.70 | 2024 | Primatrix, Neuragen, Surgimend |
| Genentech USA, INC. | $16.81 | 2025 | Ocrevus Zunovo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.